PMID: 25764678Mar 15, 2015Paper

Outline of HCV treatment

Nihon rinsho. Japanese journal of clinical medicine
Norio Akuta, Hiromitsu Kumada

Abstract

All-oral combinations of direct-acting antivirals improve efficacy and safety outcomes for patients with hepatitis C virus infection, particularly those who are poor candidates for current interferon/ribavirin-based regimens. The frequency of adverse events was also low, especially compared with historical data in patients receiving a triple regimen with NS3/4A protease inhibitor and peginterferon/ribavirin. However, there was apparent association between preexisting NS5A resistance-associated variants and virologic failure. Furthermore, both NS5A and NS3 resistance-associated variants were also detected in most patients with virologic failure. In conclusion, more effective therapeutic regimens should be selected, based on further understanding of efficacy and safety in each of drugs.

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Related Papers

Hepatology : Official Journal of the American Association for the Study of Liver Diseases
Hiromitsu KumadaEric Hughes
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology
Fumitaka SuzukiHiromitsu Kumada
BioMed Research International
Kazi Abdus Salam, Nobuyoshi Akimitsu
Hepatology : Official Journal of the American Association for the Study of Liver Diseases
Alan S WangThomas R O'Brien
© 2021 Meta ULC. All rights reserved